Clinical Trial

A Long-term Efficacy and Safety of NTQ5082 Capsules

Name: A Long-term Efficacy and Safety of NTQ5082 Capsules — clinical trial record (NCT07177872)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

NTQ5082 capsules are a small molecule CFB inhibitor. This study is a multicenter, open-label study evaluating the long-term efficacy and safety of NTQ5082 capsules in the treatment of patients with paroxysmal nocturnal hemoglobinuria

Trial Details

NCT Number	NCT07177872
Lead Sponsor	Nanjing Chia-tai Tianqing Pharmaceutical
Conditions	Paroxysmal Nocturnal Hemoglobinuria
Enrollment	78 participants
Start Date	2026-06
Primary Completion	2028-06 (estimated)
Study Completion	2028-06 (estimated)
Updated on ClinicalTrials.gov	2025-09-17